ICT Media

ICT Priorities in Pharmaceuticals - Enterprise ICT investment plans

  • KAB110104
  • 34 Pages
  • December 2013
  • ICT Media
Synopsis
This report presents the findings from a survey of 102 pharmaceutical regarding their Information & Communications Technology (ICT) investment priorities. The survey investigates the core technologies which pharmaceutical companies are investing in, including the likes of enterprise applications, security, mobility, communications & collaboration, and Cloud Computing.
Scope
Recognize pharmaceutical companies strategic objectives with regards to their ICT investments.

Identify pharmaceutical companies investment priorities based on their budget allocations across core technology categories such as enterprise applications, security, mobility, communications & collaboration, and Cloud Computing, etc.

Learn about the drivers that are influencing pharmaceutical companies investments in each technology category.

Establish how pharmaceutical companies IT budgets are currently allocated across various segments within a technology category.

Gain insight into how pharmaceutical companies plan to change their ICT budget allocations across various segments within a technology category.
Summary
Why was the report written?
In order to provide deeper insights into pharmaceutical companies ICT investment priorities and strategic objectives.

What is the current market landscape and what is changing?
Kables survey finds that apart from investing in core technologies (such as security, enterprise applications, and IT systems management), many pharmaceutical companies are looking to adopt green IT and virtualization, cloud computing, mobility, and business intelligence solutions.

What are the key drivers behind recent market changes?
Demand for such advanced technologies are increasing amongst pharmaceutical companies as these solutions will help them to reduce their costs, enhance operational efficiencies, achieve sustainability, and improve customer experience.

What makes this report unique and essential to read?
Kable Global ICT Intelligence has invested significant resources in order to interview CIOs and IT managers about their IT investment priorities. Very few IT analyst houses will have interviewed 100+ ICT decision makers in pharmaceutical industry in H2 2012.
ReasonsToBuy
The demand for security solutions is set to continue, with 87% of survey respondents planning investments in this area in the next two years, owing to the increasing adoption of enterprise mobility and rising data security threats in pharmaceutical companies.

Companies in the pharmaceutical sector are keen to deploy a cost effective supply chain solution in order to streamline their operations.

In order to curb the impact of competition and regulatory changes pharmaceuticals companies are looking to adopt various predictive analytics and modelling tools in order to make smarter business decisions by understanding the latest market trends and customer preferences.

Managing and monitoring the ever increasing volumes of information across a global organisation is a complex task, which is driving the adoption of various enterprise content management (ECM) solutions.

The increasing complexity of enterprise ICT infrastructure is consequently driving the demand for IT systems management to manage ICT assets effectively and keep them running efficiently, while at the same time removing any redundancies and wastage of resources.
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Telematics Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Telematics by the synonym itself defines the integration of telecommunications and information and communications technologies abruptly called as informatics. It can be simply the technology of transmitting, receiving, sending and ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Circulating Tumor Cells Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Circulating tumor cells (CTCs) are cells which detach from its primary or secondary tumors, enters in to the bloodstream and travel to distant organs. This is the evolving field of ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Glycobiology Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

The term glycobiology, also called as glycans, is the study of structure, function and biology of carbohydrate. They are the most essential components in living things. Merton Bernfield and colleagues ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Drug Testing Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Drug testing includes different testing methods which are conducted to detect presence of drugs in the human body. These drugs are tested through blood, sweat, saliva, oral fluid and urine. ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Tissue Engineering and Regeneration Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Tissue engineering is developed from the field of biomaterials development and refers to the practice of combining cells or tissues with biologically active molecules into functional tissues. They are mainly ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Biopsy Devises Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

A biopsy is a medical test, mainly used to detect cancer, performed by surgeons, cardiologist or by radiologist. It involves in the extraction of sample cells or tissues for examination ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

2017 © Copyright Big Market Research

View Pricing >>